Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity (ROP): A Pilot, Randomized and Prospective Study.

NCT01238471 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT01238471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01238471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity (ROP): A Pilot, Randomized and Prospective Study.
Lead sponsor
Rambam Health Care Campus
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2010
Completion date
July 31, 2012
Enrollment
20 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity